Human herpesvirus 1 Injection

Brand(s)
Imlygic
Category(s)
prescription
SPL Type(s)
Human Prescription
Master SPL
Amgen Inc (2015-10-29)
Oldest Current Product
2015-11-02
License(s)
BLA
RxNORM
INJECTION\HUMAN HERPESVIRUS 1
SPL Active
INTRALESIONAL\INJECTION, SUSPENSION\TALIMOGENE LAHERPAREPVEC
SPL Moiety
INTRALESIONAL\INJECTION, SUSPENSION\TALIMOGENE LAHERPAREPVEC

product(s) by strength(s)

1 ml talimogene laherparepvec 1000000 unt injection

product(s)(s)

#idbrandcategorylabelerfirst marketedactive ingredient(s)routedose formapplicationspl
1555130078ImlygicBLAAmgen Inc2015-11-02TALIMOGENE LAHERPAREPVECINTRALESIONALINJECTION, SUSPENSION12551864ffb680-ea8c-42fc-9649-9e8c0eb77ddb

1 ml talimogene laherparepvec 100000000 unt injection

product(s)(s)

#idbrandcategorylabelerfirst marketedactive ingredient(s)routedose formapplicationspl
1555130079ImlygicBLAAmgen Inc2015-11-02TALIMOGENE LAHERPAREPVECINTRALESIONALINJECTION, SUSPENSION12551864ffb680-ea8c-42fc-9649-9e8c0eb77ddb

spl(s)

#idtitlecategorytypelabelerlast updateversionproduct(s)
164ffb680-ea8c-42fc-9649-9e8c0eb77ddb (view SPL)These highlights do not include all the information needed to use IMLYGIC TM safely and effectively. See full prescribing information for IMLYGIC . I MLYGIC ( talimogene laherparepvec ) Suspension for intralesional injection Initial U.S. Approval: 2015prescriptionHuman PrescriptionAmgen Inc2015-10-294555130078, 555130079

Data from: LOINC, MTHSPL, NDFRT, NCIT, RxNORM, UNII